Matthew T Bennett

Summary

Publications

  1. pmc Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV
    Matthew T Bennett
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Lipids Health Dis 6:15. 2007
  2. pmc Are HIV positive patients resistant to statin therapy?
    Kevin W Johns
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Lipids Health Dis 6:27. 2007

Collaborators

Detail Information

Publications2

  1. pmc Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV
    Matthew T Bennett
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Lipids Health Dis 6:15. 2007
    ..006). Mean Apolipoprotein B100 was reduced 33% (p = 0.043). No adverse events occurred. Ezetimibe appears safe and effective in patients with HIV when added to maximally tolerated doses of lipid lowering therapy...
  2. pmc Are HIV positive patients resistant to statin therapy?
    Kevin W Johns
    Department of Medicine, University of British Columbia, Vancouver, Canada
    Lipids Health Dis 6:27. 2007
    ..This study sought to determine the efficacy of rosuvastatin on lipid parameters in HIV positive patients with HIV metabolic syndrome...